World's Best Scientists 2026 revealed!

D-Index & Metrics

Discipline name D-Index World Ranking Current World Ranking National Ranking Current National Ranking Publications Citations
Immunology 50 4227 3905 1927 1764 281 10382

John D. Roback publications per year

The chart shows the history of publications by John D. Roback between 1989 and 2025, highlighting the no. of papers published in each year and offering an overview of the publication velocity of this scholar. John D. Roback published across 37 years, from 1989 to 2025, averaging 9 papers a year. Output peaked at 43 publications in 2022. 30 of the 332 publications appeared in the last two years.

No. of publications
10 20 30 40
Bar chart. Horizontal axis: year, 1989 to 2025. Vertical axis: number of publications, 0 to 43. Peak 43 publications in 2022. 1989: 1 publication 1990: 1 publication 1991: 2 publications 1992: 3 publications 1993: 2 publications 1994: 0 publications 1995: 1 publication 1996: 0 publications 1997: 0 publications 1998: 0 publications 1999: 1 publication 2000: 1 publication 2001: 5 publications 2002: 1 publication 2003: 4 publications 2004: 11 publications 2005: 9 publications 2006: 9 publications 2007: 13 publications 2008: 4 publications 2009: 20 publications 2010: 7 publications 2011: 9 publications 2012: 8 publications 2013: 11 publications 2014: 9 publications 2015: 9 publications 2016: 9 publications 2017: 8 publications 2018: 13 publications 2019: 16 publications 2020: 15 publications 2021: 26 publications 2022: 43 publications 2023: 31 publications 2024: 18 publications 2025: 12 publications
1989 2025

332 publications in total across all disciplines

View publications per year as a table
John D. Roback: publications per year, 1989 to 2025
Year Publications
1989 1
1990 1
1991 2
1992 3
1993 2
1994 0
1995 1
1996 0
1997 0
1998 0
1999 1
2000 1
2001 5
2002 1
2003 4
2004 11
2005 9
2006 9
2007 13
2008 4
2009 20
2010 7
2011 9
2012 8
2013 11
2014 9
2015 9
2016 9
2017 8
2018 13
2019 16
2020 15
2021 26
2022 43
2023 31
2024 18
2025 12
Total 332
Download as CSV

John D. Roback publication distribution in Immunology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Immunology in 2026. The highlighted bar marks where John D. Roback sits on this spectrum.

No. of scientists
50 100 150
Bar chart with 76 bars. Horizontal axis: publications, 62–71 to 807+. Vertical axis: number of scientists, 0 to 189. Most scientists, 189, have 152–161 publications. The last bar groups every scientist with 807 publications or more. The highlighted bar, 272–281 publications, is where this scientist sits. 62–71 publications: 9 scientists 72–81 publications: 23 scientists 82–91 publications: 40 scientists 92–101 publications: 72 scientists 102–111 publications: 86 scientists 112–121 publications: 108 scientists 122–131 publications: 150 scientists 132–141 publications: 160 scientists 142–151 publications: 159 scientists 152–161 publications: 189 scientists 162–171 publications: 166 scientists 172–181 publications: 181 scientists 182–191 publications: 188 scientists 192–201 publications: 187 scientists 202–211 publications: 178 scientists 212–221 publications: 158 scientists 222–231 publications: 168 scientists 232–241 publications: 159 scientists 242–251 publications: 160 scientists 252–261 publications: 148 scientists 262–271 publications: 116 scientists 272–281 publications: 125 scientists 282–291 publications: 115 scientists 292–301 publications: 111 scientists 302–311 publications: 95 scientists 312–321 publications: 97 scientists 322–331 publications: 97 scientists 332–341 publications: 99 scientists 342–351 publications: 96 scientists 352–361 publications: 69 scientists 362–371 publications: 76 scientists 372–381 publications: 71 scientists 382–391 publications: 71 scientists 392–401 publications: 62 scientists 402–411 publications: 54 scientists 412–421 publications: 41 scientists 422–431 publications: 63 scientists 432–441 publications: 53 scientists 442–451 publications: 31 scientists 452–461 publications: 42 scientists 462–471 publications: 40 scientists 472–481 publications: 29 scientists 482–491 publications: 34 scientists 492–501 publications: 30 scientists 502–511 publications: 23 scientists 512–521 publications: 41 scientists 522–531 publications: 29 scientists 532–541 publications: 28 scientists 542–551 publications: 16 scientists 552–561 publications: 18 scientists 562–571 publications: 18 scientists 572–581 publications: 17 scientists 582–591 publications: 17 scientists 592–601 publications: 17 scientists 602–611 publications: 19 scientists 612–621 publications: 13 scientists 622–631 publications: 12 scientists 632–641 publications: 11 scientists 642–651 publications: 16 scientists 652–661 publications: 9 scientists 662–671 publications: 5 scientists 672–681 publications: 13 scientists 682–691 publications: 12 scientists 692–701 publications: 6 scientists 702–711 publications: 6 scientists 712–721 publications: 9 scientists 722–731 publications: 9 scientists 732–741 publications: 6 scientists 742–751 publications: 11 scientists 752–761 publications: 10 scientists 762–771 publications: 7 scientists 772–781 publications: 12 scientists 782–791 publications: 7 scientists 792–801 publications: 5 scientists 802–806 publications: 1 scientist 807+ publications: 100 scientists
62–71 publications 807+

This scientist: 281 publications — 59th percentile

59% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 807 publications or more.

View publications distribution as a table
Number of Immunology scientists by publication count, Research.com 2026 ranking edition. Based on 4,929 ranked scientists.
Publications Scientists This scientist
62–71 9
72–81 23
82–91 40
92–101 72
102–111 86
112–121 108
122–131 150
132–141 160
142–151 159
152–161 189
162–171 166
172–181 181
182–191 188
192–201 187
202–211 178
212–221 158
222–231 168
232–241 159
242–251 160
252–261 148
262–271 116
272–281 125 281
282–291 115
292–301 111
302–311 95
312–321 97
322–331 97
332–341 99
342–351 96
352–361 69
362–371 76
372–381 71
382–391 71
392–401 62
402–411 54
412–421 41
422–431 63
432–441 53
442–451 31
452–461 42
462–471 40
472–481 29
482–491 34
492–501 30
502–511 23
512–521 41
522–531 29
532–541 28
542–551 16
552–561 18
562–571 18
572–581 17
582–591 17
592–601 17
602–611 19
612–621 13
622–631 12
632–641 11
642–651 16
652–661 9
662–671 5
672–681 13
682–691 12
692–701 6
702–711 6
712–721 9
722–731 9
732–741 6
742–751 11
752–761 10
762–771 7
772–781 12
782–791 7
792–801 5
802–806 1
807+ 100
Download as CSV

John D. Roback D-index placement in Immunology in 2026

The chart shows the D-index (discipline H-index) distribution of Immunology scientists ranked by Research.com in 2026. The highlighted bar marks where John D. Roback sits on this spectrum.

No. of scientists
50 100 150 200
Bar chart with 60 bars. Horizontal axis: D-Index, 40–41 to 157+. Vertical axis: number of scientists, 0 to 201. Most scientists, 201, have 58–59 D-Index. The last bar groups every scientist with 157 D-Index or more. The highlighted bar, 50–51 D-Index, is where this scientist sits. 40–41 D-Index: 28 scientists 42–43 D-Index: 91 scientists 44–45 D-Index: 157 scientists 46–47 D-Index: 192 scientists 48–49 D-Index: 175 scientists 50–51 D-Index: 188 scientists 52–53 D-Index: 177 scientists 54–55 D-Index: 155 scientists 56–57 D-Index: 194 scientists 58–59 D-Index: 201 scientists 60–61 D-Index: 197 scientists 62–63 D-Index: 201 scientists 64–65 D-Index: 173 scientists 66–67 D-Index: 167 scientists 68–69 D-Index: 172 scientists 70–71 D-Index: 199 scientists 72–73 D-Index: 184 scientists 74–75 D-Index: 133 scientists 76–77 D-Index: 163 scientists 78–79 D-Index: 127 scientists 80–81 D-Index: 121 scientists 82–83 D-Index: 125 scientists 84–85 D-Index: 121 scientists 86–87 D-Index: 102 scientists 88–89 D-Index: 96 scientists 90–91 D-Index: 75 scientists 92–93 D-Index: 72 scientists 94–95 D-Index: 74 scientists 96–97 D-Index: 66 scientists 98–99 D-Index: 68 scientists 100–101 D-Index: 49 scientists 102–103 D-Index: 60 scientists 104–105 D-Index: 54 scientists 106–107 D-Index: 36 scientists 108–109 D-Index: 23 scientists 110–111 D-Index: 52 scientists 112–113 D-Index: 41 scientists 114–115 D-Index: 34 scientists 116–117 D-Index: 25 scientists 118–119 D-Index: 28 scientists 120–121 D-Index: 11 scientists 122–123 D-Index: 20 scientists 124–125 D-Index: 27 scientists 126–127 D-Index: 19 scientists 128–129 D-Index: 20 scientists 130–131 D-Index: 16 scientists 132–133 D-Index: 17 scientists 134–135 D-Index: 14 scientists 136–137 D-Index: 15 scientists 138–139 D-Index: 9 scientists 140–141 D-Index: 11 scientists 142–143 D-Index: 9 scientists 144–145 D-Index: 9 scientists 146–147 D-Index: 7 scientists 148–149 D-Index: 7 scientists 150–151 D-Index: 7 scientists 152–153 D-Index: 5 scientists 154–155 D-Index: 8 scientists 156 D-Index: 6 scientists 157+ D-Index: 96 scientists
40–41 D-Index 157+

This scientist: 50 D-Index — 15th percentile

15% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 157 D-Index or more.

View D-Index distribution as a table
Number of Immunology scientists by D-index, Research.com 2026 ranking edition. Based on 4,929 ranked scientists.
D-Index Scientists This scientist
40–41 28
42–43 91
44–45 157
46–47 192
48–49 175
50–51 188 50
52–53 177
54–55 155
56–57 194
58–59 201
60–61 197
62–63 201
64–65 173
66–67 167
68–69 172
70–71 199
72–73 184
74–75 133
76–77 163
78–79 127
80–81 121
82–83 125
84–85 121
86–87 102
88–89 96
90–91 75
92–93 72
94–95 74
96–97 66
98–99 68
100–101 49
102–103 60
104–105 54
106–107 36
108–109 23
110–111 52
112–113 41
114–115 34
116–117 25
118–119 28
120–121 11
122–123 20
124–125 27
126–127 19
128–129 20
130–131 16
132–133 17
134–135 14
136–137 15
138–139 9
140–141 11
142–143 9
144–145 9
146–147 7
148–149 7
150–151 7
152–153 5
154–155 8
156 6
157+ 96
Download as CSV

Overview

John D. Roback is an academic affiliated with Emory University in the United States. Their research primarily focuses on medicine, with a significant emphasis on infectious diseases, hematology, physiology, genetics, and molecular biology.

The scientist's work covers several key topics, including:

  • SARS-CoV-2 and COVID-19 research
  • Blood groups and transfusion
  • COVID-19 clinical research studies
  • SARS-CoV-2 detection and testing
  • Erythrocyte function and pathophysiology
  • Blood transfusion and management
  • Hemoglobinopathies and related disorders

Notable recent papers by John D. Roback include:

  • Rapid Generation of Neutralizing Antibody Responses in COVID-19 Patients, 2020, Cell Reports Medicine
  • Convalescent Plasma to Treat COVID-19, 2020, JAMA
  • Rapid Generation of Neutralizing Antibody Responses in COVID-19 Patients, 2020, bioRxiv (Cold Spring Harbor Laboratory)
  • The SARS-CoV-2 Receptor-Binding Domain Preferentially Recognizes Blood Group A, 2021, Blood Advances
  • Quantification of Occupational and Community Risk Factors for SARS-CoV-2 Seropositivity Among Health Care Workers in a Large U.S. Health Care System, 2021, Annals of Internal Medicine

Frequent co-authors collaborating with Roback include:

  • Sean R. Stowell
  • Andrew S. Neish
  • Hans Verkerke
  • Narayanaiah Cheedarla
  • Cassandra D. Josephson

The main publication venues where Roback's work appears are:

  • Transfusion
  • bioRxiv (Cold Spring Harbor Laboratory)
  • Blood
  • Open Forum Infectious Diseases
  • Blood Advances

John D. Roback's research contributions are concentrated largely on infectious diseases and hematology, with a substantial body of work addressing COVID-19 and blood transfusion topics. Their presence in both peer-reviewed journals and preprint repositories illustrates participation in rapid dissemination of findings, particularly in the context of the SARS-CoV-2 pandemic.

Best Publications

  • Convalescent Plasma to Treat COVID-19: Possibilities and Challenges.

    John D. Roback;Jeannette Guarner

  • Recipient inflammation affects the frequency and magnitude of immunization to transfused red blood cells

    Jeanne E. Hendrickson;Maxime Desmarets;Seema S. Deshpande;Traci E. Chadwick

  • Blood Transfusion and Breast Milk Transmission of Cytomegalovirus in Very Low-Birth-Weight Infants A Prospective Cohort Study

    Cassandra D. Josephson;Angela M. Caliendo;Kirk A. Easley;Andrea Knezevic

  • Inflammation enhances consumption and presentation of transfused RBC antigens by dendritic cells.

    Jeanne E. Hendrickson;Traci E. Chadwick;John D. Roback;Christopher D. Hillyer

  • Platelets confound the measurement of extracellular miRNA in archived plasma.

    Adam J. Mitchell;Warren D. Gray;Salim S. Hayek;Yi-An Ko

  • CMV DNA is rarely detected in healthy blood donors using validated PCR assays.

    John D. Roback;W. Lawrence Drew;Megan E. Laycock;Deborah Todd

  • The effect of platelet lysate fibrinogen on the functionality of MSCs in immunotherapy.

    Ian B. Copland;Marco A. Garcia;Edmund K. Waller;John D. Roback

  • Daratumumab (anti-CD38) induces loss of CD38 on red blood cells

    Harold C. Sullivan;Christian Gerner-Smidt;Ajay K. Nooka;Connie M. Arthur

  • The SARS-CoV-2 receptor-binding domain preferentially recognizes blood group A.

    Shang-Chuen Wu;Connie M Arthur;Jianmei Wang;Hans Verkerke

  • Metabolic pathways that correlate with post-transfusion circulation of stored murine red blood cells.

    Karen de Wolski;Xiaoyoun Fu;Larry J. Dumont;John D. Roback

  • IFN-γ and indoleamine 2,3-dioxygenase signaling between donor dendritic cells and T cells regulates graft versus host and graft versus leukemia activity.

    Ying Lu;Cynthia R. Giver;Akshay Sharma;Jian Ming Li

  • BDNF‐activated Sianal Transduction in Rat Cortical Glial Cells

    John D. Roback;H. Nicholas Marsh;Martha Downen;H. Clive Palfrey

  • Latent cytomegalovirus infection exacerbates experimental colitis.

    Chukwuma Onyeagocha;Mohammad S. Hossain;Amrita Kumar;Rheinallt M. Jones

  • Determinants of Neutralizing Antibody Response After SARS CoV-2 Vaccination in Patients With Myeloma

    Unknown

  • Multidisciplinary assessment of the Abbott BinaxNOW SARS-CoV-2 point-of-care antigen test in the context of emerging viral variants and self-administration.

    Jennifer K. Frediani;Joshua M. Levy;Anuradha Rao;Leda Bassit

  • Discrete Toll-like receptor agonists have differential effects on alloimmunization to transfused red blood cells

    Jeanne E. Hendrickson;John D. Roback;Christopher D. Hillyer;Kirk A. Easley

  • Flagellin, a TLR5 Agonist, Reduces Graft-versus-Host Disease in Allogeneic Hematopoietic Stem Cell Transplantation Recipients While Enhancing Antiviral Immunity

    Mohammad S. Hossain;David L. Jaye;Brian P. Pollack;Brian P. Pollack;Alton B. Farris

  • An automatable format for accurate immunohematology testing by flow cytometry.

    John D. Roback;Sheilagh Barclay;Christopher D. Hillyer

  • Anemia induces gut inflammation and injury in an animal model of preterm infants

    Connie M. Arthur;Demet Nalbant;Henry A. Feldman;Bejan J. Saeedi

  • Marginal zone B cells mediate a CD4 T-cell-dependent extrafollicular antibody response following RBC transfusion in mice.

    Patricia E Zerra;Seema R Patel;Ryan Philip Jajosky;Connie M Arthur

  • Longitudinal monitoring of WBC subsets in packed RBC units after filtration: implications for transfusion transmission of infections.

    J.D. Roback;R.A. Bray;C.D. Hillyer

  • Multiploid CD61+ cells are the pre-dominant cell lineage infected during acute dengue virus infection in bone marrow.

    Kristina B. Clark;Sansanee Noisakran;Sansanee Noisakran;Nattawat Onlamoon;Nattawat Onlamoon;Hui-Mien Hsiao

  • AABB Committee Report: reducing transfusion-transmitted cytomegalovirus infections

    Nancy M. Heddle;Nancy M. Heddle;Michael Boeckh;Brenda Grossman;Jessica Jacobson

  • The Leukocyte Antibody Prevalence Study-II (LAPS-II): a retrospective cohort study of transfusion-related acute lung injury in recipients of high-plasma-volume human leukocyte antigen antibody–positive or –negative components

    Steven H. Kleinman;Darrell J. Triulzi;Edward L. Murphy;Patricia M. Carey

  • Antibody Profiles According to Mild or Severe SARS-CoV-2 Infection, Atlanta, Georgia, USA, 2020.

    William T. Hu;J. Christina Howell;Tugba Ozturk;Karima Benameur

Frequent Co-Authors

James C. Zimring
James C. Zimring University of Washington
Kirk A. Easley
Kirk A. Easley Emory University
Edmund K. Waller
Edmund K. Waller Emory University
Steven L. Spitalnik
Steven L. Spitalnik Columbia University
Jeanne E. Hendrickson
Jeanne E. Hendrickson Yale University
Andrew T. Gewirtz
Andrew T. Gewirtz Georgia State University
Christopher R. Flowers
Christopher R. Flowers The University of Texas MD Anderson Cancer Center
Sagar Lonial
Sagar Lonial Emory University

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

For those interested in advancing their careers in immunology and related healthcare fields, exploring online degree options can be a strategic move. Many professionals pursue specialized programs such as the cheapest psych np programs online to enhance their qualifications without incurring excessive costs.

Understanding potential earnings is crucial when considering further education. For example, individuals earning a Doctor of Nursing Practice (DNP) often evaluate how much does a dnp make varies by state and specialization, offering insight into long-term financial benefits.

Career transitions are also common within healthcare, and those with a Family Nurse Practitioner (FNP) background might seek guidance on fnp to acute care np pathways, allowing them to move into specialized, fast-paced environments.

For accelerated advancement, professionals can consider accelerated np programs that offer a faster track to becoming a nurse practitioner. These programs are ideal for those ready to quickly expand their expertise and leadership roles.

Best Scientists Citing John D. Roback

Trending Scientists

Recently Published Articles